Advertisement
Alumis Inc.

Alumis Inc. Fundamental Analysis

ALMSNASDAQ
HealthcareBiotechnology
$30.30
$0.56(1.88%)
U.S. Market opens in 15h 20m
Advertisement

Alumis Inc. Fundamental Analysis

Alumis Inc. (ALMS) shows weak financial fundamentals with a PE ratio of -15.93, profit margin of -28.26%, and ROE of -54.63%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position13.80%
PEG Ratio-0.11
Current Ratio7.51

Areas of Concern

ROE-54.63%
Operating Margin-53.64%
We analyze ALMS's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -2686.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-2686.3/100

We analyze ALMS's fundamental strength across five key dimensions:

Efficiency Score

Weak

ALMS struggles to generate sufficient returns from assets.

ROA > 10%
-35.35%

Valuation Score

Excellent

ALMS trades at attractive valuation levels.

PE < 25
-15.93
PEG Ratio < 2
-0.11

Growth Score

Weak

ALMS faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

ALMS maintains a strong and stable balance sheet.

Debt/Equity < 1
0.06
Current Ratio > 1
7.51

Profitability Score

Weak

ALMS struggles to sustain strong margins.

ROE > 15%
-5462.78%
Net Margin ≥ 15%
-28.26%
Positive Free Cash Flow
No

Key Financial Metrics

Is ALMS Expensive or Cheap?

P/E Ratio

ALMS trades at -15.93 times earnings. This suggests potential undervaluation.

-15.93

PEG Ratio

When adjusting for growth, ALMS's PEG of -0.11 indicates potential undervaluation.

-0.11

Price to Book

The market values Alumis Inc. at 6.71 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

6.71

EV/EBITDA

Enterprise value stands at -9.14 times EBITDA. This is generally considered low.

-9.14

How Well Does ALMS Make Money?

Net Profit Margin

For every $100 in sales, Alumis Inc. keeps $-28.26 as profit after all expenses.

-28.26%

Operating Margin

Core operations generate -53.64 in profit for every $100 in revenue, before interest and taxes.

-53.64%

ROE

Management delivers $-54.63 in profit for every $100 of shareholder equity.

-54.63%

ROA

Alumis Inc. generates $-35.35 in profit for every $100 in assets, demonstrating efficient asset deployment.

-35.35%

Following the Money - Real Cash Generation

Operating Cash Flow

Alumis Inc. generates limited operating cash flow of $-371.38M, signaling weaker underlying cash strength.

$-371.38M

Free Cash Flow

Alumis Inc. generates weak or negative free cash flow of $-372.15M, restricting financial flexibility.

$-372.15M

FCF Per Share

Each share generates $-3.02 in free cash annually.

$-3.02

FCF Yield

ALMS converts -10.02% of its market value into free cash.

-10.02%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-15.93

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.11

vs 25 benchmark

P/B Ratio

Price to book value ratio

6.71

vs 25 benchmark

P/S Ratio

Price to sales ratio

447.04

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.06

vs 25 benchmark

Current Ratio

Current assets to current liabilities

7.51

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.55

vs 25 benchmark

ROA

Return on assets percentage

-0.35

vs 25 benchmark

ROCE

Return on capital employed

-0.75

vs 25 benchmark

How ALMS Stacks Against Its Sector Peers

MetricALMS ValueSector AveragePerformance
P/E Ratio-15.9329.80 Better (Cheaper)
ROE-54.63%378.00% Weak
Net Margin-2825.70%-13387.00% (disorted) Weak
Debt/Equity0.060.77 Strong (Low Leverage)
Current Ratio7.515.05 Strong Liquidity
ROA-35.35%-98.00% (disorted) Weak

ALMS outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Alumis Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ